Belen Aparicio, Patrick Theunissen, Sandra Hervas-Stubbs, Puri Fortes, & Pablo Sarobe. (2024). Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies. Taylor & Francis Group.
Chicago Style (17th ed.) CitationBelen Aparicio, Patrick Theunissen, Sandra Hervas-Stubbs, Puri Fortes, and Pablo Sarobe. Relevance of Mutation-derived Neoantigens and Non-classical Antigens for Anticancer Therapies. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationBelen Aparicio, et al. Relevance of Mutation-derived Neoantigens and Non-classical Antigens for Anticancer Therapies. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.